We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development
Product News

“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development

“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development
Product News

“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Hypha Discovery, has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide.

Over the last eight years, Hypha has developed a microbial and mammalian biotransformation platform, for biotransforming drugs and agrochemicals into metabolites and environmental fate derivatives that could not be made using conventional synthetic methods.

It has added to its existing portfolio of services the capability to chemically synthesize glucuronide metabolites using proprietary methods that modify the parent compound. Thus, Hypha is offering a combination of both biological and chemical techniques, i.e. a one-stop offering for all metabolite exploration needs, designed such that clients could quickly establish a method to identify and scale up any type of metabolite.

Advertisement